Figure 2.
Nomograms for predicting the probability of lung metastasis (A) in patients with malignant primary osseous spinal neoplasms (MPOSN), and the 3- and 5-year cancer-specific survival (CSS) in the lung metastasis subgroups (B) (Grade I, well differentiated; Grade II, moderately differentiated; Grade III, poorly differentiated; Grade IV, undifferentiated).
